1043914-08-4

Basic information

• Product Name: 3-({4-[(2-{[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy}ethyl)amino]-4-oxobutanoyl}oxy)olean-12-en-28-oic acid
• Synonyms: 3-({4-[(2-{[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy}ethyl)amino]-4-oxobutanoyl}oxy)olean-12-en-28-oic acid
• CAS NO: 1043914-08-4
• Molecular Weight: 824.048
• Mol File: 1043914-08-4.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-({4-[(2-{[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy}ethyl)amino]-4-oxobutanoyl}oxy)olean-12-en-28-oic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-({4-[(2-{[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy}ethyl)amino]-4-oxobutanoyl}oxy)olean-12-en-28-oic acid(1043914-08-4)
• EPA Substance Registry System: 3-({4-[(2-{[5-oxido-4-(phenylsulfonyl)-1,2,5-oxadiazol-3-yl]oxy}ethyl)amino]-4-oxobutanoyl}oxy)olean-12-en-28-oic acid(1043914-08-4)

Safety Data

• Hazardous Substances Data: 1043914-08-4(Hazardous Substances Data)

Upstream product

• 186408-95-7 4-(2-aminoethoxy)-3-(benzenesulfonyl)-1,2,5-oxadiazole-2-oxide 
• 4847-30-7 3β-[3-(carboxyl)propionyloxy]-olean-12-en-28-oic acid 

Relevant articles and documents

Design, synthesis, and antihepatocellular carcinoma activity of nitric oxide releasing derivatives of oleanolic acid

Novel furoxan-based nitric oxide (NO) releasing derivatives of oleanolic acid (OA) were synthesized for potential therapy of liver cancers. Six compounds produced high levels of NO in human hepatocellular carcinoma (HCC) cells and exhibited strong cytotoxicity selectively against HCC in vitro. Treatment with 8b or 16b significantly inhibited the growth of HCC tumors in vivo. These data provide a proof-in-principle that furoxan/OA hybrids may be used for therapeutic intervention of human liver cancers.